Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD

[OmShanti]

A positive update from Sage:

https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-announces-positive-interim-topline-zuranolone

[Crazycalypso]

Perfect. This really should be getting more traction in my opinion.